Schacterle Amy (CIK 2042021) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-21). Recent activity: Buy ABOS (84,600 shares), Sell ABOS (1,097 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-21 | Acumen Pharmaceuticals, Inc. (ABOS) | Chief Regulatory Officer | Buy | 84,600 | $0 |
| 2026-01-09 | Acumen Pharmaceuticals, Inc. (ABOS) | Chief Regulatory Officer | Sell | 1,097 | $2,172 |
Source: SEC Form 4 filings · as of 2026-01-21